Despite massive public health efforts and media attention, elevated blood lead levels (BLL) remain a serious public health concern, particularly when they occur in children, who are more susceptible to the toxic effects of the lead. In the 1950's lead was used in water pipes, petroleum, and paint, causing systemic exposure in adults and children, with resultant lead toxicity. Since then, efforts to reduce exposure which has dramatically reduced the incidence of elevated lead levels in the general population. However, there continues to be pandemics and isolated cases of lead poisoning in the United States. In 2015, the water supply in Flint, Michigan was found to be contaminated with lead, and more recently, in 2018, Milwaukee state was found to be mismanaging its childhood lead poisoning prevention program resulting in an increase in the incidence of lead poisonings 1, 2 . Although there has been success in lowering environmental levels of lead, research has demonstrated that the level of lead that can cause morbidity is lower than previously believed. In 2012, the reference level for an abnormal concentration of lead was lowered from 10 to 5 g/dL 3 . This was the latest in a series of changes of successive lowering of the reference levels going back to 1961, when the CDC defined 60 g/dL as the reference level 4 . These changes were the result of a better appreciation of the toxicity.
Lead poisoning secondary to retained bullet fragments (RBF) is currently considered a rare phenomenon, even though it is known that lead levels are often elevated in people with RBF 5,6 . Intraarticular bullet fragments are known to cause elevated lead levels as the pH in the synovial fluid results in lead leaching from the bullet, and their removal is recommended 6 . However, there has been no consensus on monitoring BLLs in people with extra-articular RBFs 6, 7 . Lead levels have also been found to be elevated in people frequenting shooting ranges due to discharge of lead dust upon firing a bullet with lead primer or containing lead 8 .
The symptoms of lead toxicity are usually vague and non-specific and include abdominal pain, vomiting, constipation, fatigue, and weight loss. Because the occurrence is rare and the symptoms non-specific, the diagnosis of lead toxicity may be delayed, as it was in our case report, or even missed until a post-mortem diagnosis. This delay can result in profound consequences, such as our patient who developed severe motor sensory neuropathy with quadriparesis and allodynia 9 . Long term exposure to lead with BLLs above 5-10 g/dL has also been reported to cause anemia, hypertension, renal dysfunction, and brain injury 10 . It also affects fertility as chronic lead exposure in men reduces fertility and also to increased frequency of miscarriage in women 10 .
At the time of our publication, there was no published protocol for checking lead levels in patients with extrasynovial retained bullet fragments. As in our case and with others, there can be a long delay between the gunshot wound and the onset of lead toxicity. This fact, when coupled with the rarity of the diagnosis, compounds the difficulty in suspecting lead toxicity 11, 12 . After our reported case, we measured BLLs in patients admitted to our acute inpatient rehabilitation facility that have non-articular RBF. Thus far we have collected BLLs in five consecutive patients. The time from gunshot wound (GSW) to lead level was an average of 8 years (4 days to 34 years) and we stratified the results by the presence of lead toxicity, co-morbidities, and location of RBF. Lead levels ranged from 2.0 g/dL to 48.1 g/dL with 5/6 patients having BLLs above 5 g/dL. The two highest levels (48.0 and 18.7 g/dL) were seen in patients with recent GSWs with multiple fragments. 5/6 patients had HTN, 1/6 patients had ESRD, 3/6 patients were anemic, 0/6 patients had documented cognitive dysfunction on a mini-mental status examination 13 . This preliminary data is consistent with the current literature that patients with RBFs are at risk for elevated BLLs and lead toxicity. This supports the need for the development of a protocol for checking BLLs in patients with RBF. Just recently, Nickel et al. recommended that in all cases of extra-articular retained missiles that there be a lead level checked at hospital admission, discharge and monthly intervals until three months' post injury and then again at one year post injury 5 .
GSW injury with RBF is a frequent occurrence in America. In addition, there is an increase in American soldiers with GSWs and injury from improvised explosive devices (IEDs). Retained fragments from either injury may contain lead which may also result in an increase in lead toxicity in this population. The severity of consequences with chronic exposure to lead levels above 5-10 g/ dL, and our preliminary findings as well as the data of frequent elevated BLL in people with RBF 5,6,11,12 support the recent recommendation that patients with retained bullet fragments should have periodic assessments of lead levels and be monitored for known clinical symptoms of lead toxicity 5 . Future studies are required to ensure the appropriate time intervals of checking BLLs. Since toxicity can occur from the chronic lead levels as low as 5-10 g/dL, these studies also are needed to determine when treatment, either with chelation therapy or attempted fragment removal, should be undertaken.
